You will discover the world of Market Access in the pharmaceutical industry and acquire the skills necessary to stand out in this growing field"

Why Study at TECH?

TECH is the world's largest 100% online business school. It is an elite business school, with a model based on the highest academic standards. A world-class center for intensive managerial skills education.   

TECH is a university at the forefront of technology, and puts all its resources at the student's disposal to help them achieve entrepreneurial success"

At TECH Global University

Innovation

The university offers an online learning model that balances the latest educational technology with the most rigorous teaching methods. A unique method with the highest international recognition that will provide students with the keys to develop in a rapidly-evolving world, where innovation must be every entrepreneur’s focus.

"Microsoft Europe Success Story", for integrating the innovative, interactive multi-video system. 

The Highest Standards

Admissions criteria at TECH are not economic. Students don't need to make a large investment to study at this university. However, in order to obtain a qualification from TECH, the student's intelligence and ability will be tested to their limits. The institution's academic standards are exceptionally high...  

95% of TECH students successfully complete their studies.

Networking

Professionals from countries all over the world attend TECH, allowing students to establish a large network of contacts that may prove useful to them in the future.  

100,000+ executives prepared each year, 200+ different nationalities.

Empowerment

Students will grow hand in hand with the best companies and highly regarded and influential professionals. TECH has developed strategic partnerships and a valuable network of contacts with major economic players in 7 continents.  

500+ collaborative agreements with leading companies.

Talent

This program is a unique initiative to allow students to showcase their talent in the business world. An opportunity that will allow them to voice their concerns and share their business vision. 

After completing this program, TECH helps students show the world their talent.

Multicultural Context

While studying at TECH, students will enjoy a unique experience. Study in a multicultural context. In a program with a global vision, through which students can learn about the operating methods in different parts of the world, and gather the latest information that best adapts to their business idea.

TECH students represent more than 200 different nationalities.  

Learn with the best

In the classroom, TECH’s teaching staff discuss how they have achieved success in their companies, working in a real, lively, and dynamic context. Teachers who are fully committed to offering a quality specialization that will allow students to advance in their career and stand out in the business world. 

Teachers representing 20 different nationalities. 

TECH strives for excellence and, to this end, boasts a series of characteristics that make this university unique:   

Analysis

TECH explores the student’s critical side, their ability to question things, their problem-solving skills, as well as their interpersonal skills.  

Academic Excellence

TECH offers students the best online learning methodology. The university combines the Relearning method (postgraduate learning methodology with the best international valuation) with the Case Study. Tradition and vanguard in a difficult balance, and in the context of the most demanding educational itinerary. 

TECH is the world’s largest online university. It currently boasts a portfolio of more than 10,000 university postgraduate programs. And in today's new economy, volume + technology = a ground-breaking price. This way, TECH ensures that studying is not as expensive for students as it would be at another university.   

At TECH, you will have access to the most rigorous and up-to-date case analyses in academia” 

The content of this Postgraduate diploma in Access Market in Pharma Biotech is composed of relevant topics in the Biotech and Biotechnology field. In this sense, the student will explore the present and future vision of healthcare, taking into account the age pyramid and the challenge of maintaining costs in an aging population. In addition, the supporting documents and tools that will support price and reimbursement negotiation, access to regions and hospitals, and product positioning in therapeutic guidelines will be analyzed.

You will have at your disposal specialized readings and a whole series of multimedia resources with which you will understand the healthcare system and its impact on the pharmaceutical industry" 

Piano di studi

This program will cover a variety of topics relevant to the Access Marketing and pharmaceutical industry. First, it will emphasize the need to understand the different types of patients and learn how to communicate with them without generating conflicts. In addition, the official bodies involved in the regulation of new drugs, both at national and regional level, will be analyzed, and the processes of authorization, assessment, pricing and reimbursement of drugs will be studied. It will also detail the steps necessary to achieve a successful entry of a new drug into the market.

In addition, specific requirements for senior management positions in the sector will be examined, taking into account the shortage of qualified leaders in the industry. It will provide the necessary tools to develop effective leadership skills. In addition, a strategic access plan will be designed that will define who the key players are, when and how contact will be established with the different decision-makers and influencers. This strategic approach will ensure an appropriate approach to building relationships and successfully negotiating market entry.

Being consistent with this, TECH has developed a Postgraduate diploma, with the purpose of providing the business specialist with the indispensable tools and knowledge in the pharmaceutical field and the Access Marketing industry. As a result, the participants will become an outstanding connoisseur of the subject and will be able to advance significantly in their professional careers.

In this sense, an educational proposal is presented in a 100% online format. Under these circumstances, the student will have a large library of teaching materials, which will facilitate the learning process. In this way, the participant will be guaranteed easy access from any electronic device with an Internet connection. In this way, the syllabus will be adapted to individual and collective professional objectives, stimulating the expert to achieve excellence in the pharmaceutical and biotechnological field. In addition, cutting-edge content based on the latest trends will be offered, which, together with the Relearning method, will allow you to understand complex concepts in less time 
and in a more efficient manner.

This Postgraduate diploma takes place over 6 months and is divided into 3 modules:

Modulo 1. Market Access (1). Organization and Processes
Modulo 2. Market Access (2). Tools and Strategy
Modulo 3. Digital Health Management: Technological Innovation in the Health Sector 

Dove, quando e come si svolge?

TECH offre la possibilità di svolgere questo Postgraduate diploma in Access Market in Pharma Biotech completamente online. Durante i 12 mesi della specializzazione, lo studente potrà accedere a tutti i contenuti di questo programma in qualsiasi momento, il che gli consente di autogestire il suo tempo di studio.

Module 1. Market access (1) Organization and Processes

1.1. Market Access in the Pharmaceutical Industry

1.1.1. What Do We Mean by Market Access?
1.1.2. Why Is a Market Access Department Necessary?
1.1.3. Market Access Department Functions
1.1.4. Conclusions

1.2. Health System in Spain. BORRAR

1.2.1. BORRAR Organization, Structure and Function. BORRAR
1.2.2. BORRAR
1.2.3. Regional Health Service. BORRAR
1.2.4. Organization, Structure and Function. BORRAR

1.3. Authorization and Registrationof New Medicines

1.3.1. Health Authorities
1.3.2. European Medicines Agency (EMA)
1.3.3. BORRAR
1.3.4. Ministry of Health. BORRAR
1.3.5. New Drug Marketing Authorization Process: Centralized, Decentralized and Mutual Recognition Processes

1.4. New Drug Assessment at the National Level

1.4.1. Health Technology Assessment Agencies
1.4.2. Relations
1.4.3. Europe
1.4.4. Spanish. BORRAR
1.4.5. Therapeutic Positioning Reports (TPR)
1.4.6. Decision Makers and Influencers

1.5. Other New Drug Assessments

1.5.1. GENESIS Group Assessments
1.5.2. Regional Assessments
1.5.3. Assessments in Hospital Pharmacies: Pharmacy and Therapeutics Committees
1.5.4. Other Assessments

1.6. From Drug Approval to Availability to The Patient

1.6.1. New Drug Pricing and Reimbursement Application Process
1.6.2. Marketing and Financing Conditions
1.6.3. Procedure for Access to Medicinesat Hospital Level
1.6.4. Procedure for Access to Medication Dispensed in Street Pharmacies
1.6.5. Access to Generic and Biosimilar Drugs

1.7. Drug Financing

1.7.1. Traditional Versus New Financing Schemes
1.7.2. Innovative Agreements
1.7.3. Risk-Sharing Agreements (RSAs)
1.7.4. Types of ARC
1.7.5. Criteria for Selecting The ARC

1.8. Drug Purchasing Process

1.8.1. Public Procurement
1.8.2. Centralized Purchasing  of Medicines and Health Products
1.8.3. Framework Agreements
1.8.4. Conclusions

1.9. Market Access Department (1) Professional Profiles

1.9.1. Evolution of The Market Access Professional Profile
1.9.2. Market Access Professional Profiles
1.9.3. Market Access Manager
1.9.4. Pharmacoeconomics
1.9.5. Pricing
1.9.6. Key Account Manager

1.10. Market Access Department (2) Interaction with Other Departments of The Pharmaceutical Industry

1.10.1. Marketing and Sales
1.10.2. Medical Department
1.10.3. Institutional Relations 
1.10.4. Regulatory 
1.10.4. Communication 

Module 2. Market access (2) Tools and Strategy

2.1. Market Access Planning for a Drug

2.1.1. Analysis of The Current Scenario: Management of The Disease, Competitors
2.1.2. Segmentation of Regions and Accounts
2.1.3. Scientific Societies
2.1.4. Patient Associations
2.1.5. Designing the Corporate Strategy
2.1.6. Strategy Implementation Chronology

2.2. Market Access Management of a Drug

2.2.1. Regional Access Management
2.2.2. Access to The Hospital Drug Market Hospital Pharmacy Management and Strategy
2.2.3. Access to the Market for Street Pharmacy Drugs
2.2.4. Management and strategy for Primary Care Pharmacists

2.3. Clinical Value of a Drug

2.3.1. Value Based on Clinical Development
2.3.2. Real Life Studies
2.3.3. (RWD/RWE)
2.3.4. Conclusions

2.4. Value Perceived by The Patient

2.4.1. Patient Reported Outcomes (PRO)
2.4.2. Health-Related Quality of Life (HRQOL)
2.4.3. Satisfaction with Treatment
2.4.4. Incorporation of Patient Preferences

2.5. Economic Analysis Types

2.5.1. Types of Economic Analysis
2.5.2. Parameters to Be Defined
2.5.3. Partial Economic Assessments
2.5.4. Costs and Burden of  Disease
2.5.5. Cost Consequence

2.6. Economic Analysis Studies

2.6.1. Budget Impact Studies
2.6.2. Market Growth
2.6.3. Associated Risks
2.6.4. Intellectual Property

2.7. Economic Analysis Assessments

2.7.1. Complete Economic Assessments
2.7.2. Cost-Effectiveness Analysis
2.7.3. Cost-Utility Analysis
2.7.4. Cost-Benefit Analysis
2.7.5. Decision Rules

2.8. Drug Value Dossier

2.8.1. Value Dossier Contents
2.8.2. Clinical Value of The Drug
2.8.3. Economic Value of The Drug
2.8.4. Demonstrating The Value of The Drug to The Healthcare System
2.8.5. Adaptation of The Dossier to Different Autonomous Communities

2.9. Documents Required for Price and Reimbursement Request

2.9.1. Required Documents
2.9.2. Optional Documents
2.9.3. Price Documents
2.9.4. Reimbursement Documents

2.10. New Trends

2.10.1. Value-Based Purchasing
2.10.2. Multicriteria Analysis (MCA)
2.10.3. Innovative Public Procurement
2.10.4. Latest Trends

Module 3. Digital Health Management: Technological Innovation in the Health Sector

3.1. Hospital Information Systems

3.1.1. Implementation
3.1.2. Hospital Information Systems Management
3.1.3. Electronic Medical Records
3.1.4. Information Systems Interoperability

3.2. Telemedicine and Digital Health

3.2.1. Remote Medical Consultations
3.2.2. Telemonitoring Platforms
3.2.3. Patient Follow-Up
3.2.4. Mobile Health and Wellness Applications

3.3. Big Data and Data Analysisin Healthcare

3.3.1. Management and Analysis of Large Volumes of Healthcare Data
3.3.2. Use of Predictive Analytics for Decision Making
3.3.3. Privacy
3.3.4. Health Data Security

3.4. Artificial Intelligence and Machine Learning in Healthcare

3.4.1. Artificial Intelligence Applications in Medical Diagnostics
3.4.2. Machine Learning Algorithms for Pattern Detection
3.4.3. Chatbots
3.4.4. Virtual Assistants in Medical Care

3.5. Internet of Things (IoT) in Healthcare

3.5.1. Connected Medical Devices and Remote Monitoring
3.5.2. Intelligent Hospital Infrastructures
3.5.3. IoT Applications in Inventory Management
3.5.4. Supplies

3.6. Cybersecurity in Healthcare

3.6.1. Health Data Protectionand Regulatory Compliance
3.6.2. Prevention of Cyber Attacks
3.6.3. Ransomware
3.6.4. Security Audits and Incident Management

3.7. Virtual Reality (RV) and Augmented Reality(AR) in Medicine

3.7.1. Medical Training Using VR Simulators
3.7.2. AR Applications in Assisted Surgery
3.7.3. Surgical Guides
3.7.4. VR Therapy and Rehabilitation

3.8. Medical Robotics

3.8.1. Use of Surgical Robots in Medical Procedures
3.8.2. Task Automation in Hospitals and Laboratories
3.8.3. Prosthesis
3.8.4. Robotic Assistance in Rehabilitation

3.9. Medical Image Analysis

3.9.1. Medical Image Processingand Computational Analysis
3.9.2. Computer-Aided Image Diagnosis
3.9.3. Real-Time Medical Imaging
3.9.4. 3D

3.10. Blockchain in Healthcare

3.10.1. Security and Traceability of Health Data with Blockchain
3.10.2. Exchange of Medical Information between Institutions
3.10.3. Management of Informed Consents
3.10.4. Privacy

With the Relearning method, you will reduce your study hours and strengthen your understanding in the long run"